Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation-Reference-Cited by-同舟云学术

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation

Published:2022-10-05 Issue:12 Volume:15 Page:2958-2970
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Petrucci Giovanna¹,Giaretta Alberto²,Ranalli Paola³,Cavalca Viviana⁴,Dragani Alfredo³,Porro Benedetta⁴,Hatem Duaa¹,Habib Aida⁵^ORCID,Tremoli Elena⁶,Patrono Carlo¹,Rocca Bianca¹^ORCID

Affiliation:

1. Department of Safety and Bioethics, Section of Pharmacology Catholic University School of Medicine Rome Italy

2. Department of Pathology University of Cambridge Cambridge UK

3. Department of Hematology S. Spirito Hospital Pescara Italy

4. Centro Cardiologico Monzino, IRCCS Milan Italy

5. Department of Basic Medical Sciences, College of Medicine, QU Health Qatar University Doha Qatar

6. Maria Cecilia Hospital Cotignola Italy

Funder

Cancer Research UK

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13415

Reference51 articles.

1. Platelet activation and inhibition in polycythemia vera and essential thrombocythemia

2. Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study

3. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

4. Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia

5. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial;American Journal of Hematology;2024-06-15

2. Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?;American Journal of Hematology;2024-05-16

3. Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays;Scientific Reports;2024-03-06

4. Precision antiplatelet therapy;Research and Practice in Thrombosis and Haemostasis;2023-03

5. Low- or high-dose preventive aspirin use and risk of death from all-cause, cardiovascular disease, and cancer: A nationally representative cohort study;Frontiers in Pharmacology;2023-02-15